UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 30

Sortiert nach

Dominant Role of Peroxiredoxin/JNK Axis in Stemness Regulation During Neurogenesis from Embryonic Stem Cells

Stem cells (Dayton, Ohio), 2014-04, Vol.32 (4), p.998-1011

2014

Volltextzugriff (PDF)

Peroxiredoxin I deficiency increases pancreatic β‑cell apoptosis after streptozotocin stimulation via the AKT/GSK3β signaling pathway

Molecular medicine reports, 2020-09, Vol.22 (3), p.1831-1838

2020

Volltextzugriff (PDF)

BRM270 Suppresses Cervical Cancer Stem Cell Characteristics and Progression by Inhibiting SOX2

In vivo (Athens), 2020-05, Vol.34 (3), p.1085-1094

2020

Volltextzugriff (PDF)

Microglial peroxiredoxin V acts as an inducible anti-inflammatory antioxidant through cooperation with redox signaling cascades

Journal of neurochemistry, 2010-07, Vol.114 (1), p.39-50

2010

Volltextzugriff (PDF)

Peroxiredoxin II exerts neuroprotective effects by inhibiting endoplasmic reticulum stress and oxidative stress-induced neuronal pyroptosis

Molecular biology reports, 2024-12, Vol.51 (1), p.607-607, Article 607

2024

Volltextzugriff (PDF)

Knockdown of peroxiredoxin V increases glutamate‑induced apoptosis in HT22 hippocampal neuron cells

Molecular medicine reports, 2018-06, Vol.17 (6), p.7827-7834

2018

Volltextzugriff (PDF)

Thioredoxin-Interacting Protein Regulates Hematopoietic Stem Cell Quiescence and Mobilization under Stress Conditions

The Journal of immunology (1950), 2009-08, Vol.183 (4), p.2495-2505

2009

Volltextzugriff (PDF)

16α,17α-Epoxypregnenolone-20-oxime Prevent LPS-Induced NO Production and iNOS Expression in BV-2 Microglial Cells by Inhibiting JNK Phosphorylation

Biological and Pharmaceutical Bulletin, 2014/07/01, Vol.37(7), pp.1096-1102

2014

Volltextzugriff (PDF)

Characterization of neural cell types expressing peroxiredoxins in mouse brain

Neuroscience letters, 2005-06, Vol.381 (3), p.252-257

2005

Volltextzugriff (PDF)

Peroxiredoxin I is a ROS/p38 MAPK-dependent inducible antioxidant that regulates NF-κB-mediated iNOS induction and microglial activation

Journal of neuroimmunology, 2013-06, Vol.259 (1), p.26-36

2013

Volltextzugriff (PDF)

Peroxiredoxin II with dermal mesenchymal stem cells accelerates wound healing

Aging (Albany, NY.), 2021-05, Vol.13 (10), p.13926-13940

2021

Volltextzugriff (PDF)

Peroxiredoxin I Is an Indicator of Microglia Activation and Protects against Hydrogen Peroxide-Mediated Microglial Death

Biological and Pharmaceutical Bulletin, 2008/05/01, Vol.31(5), pp.820-825

2008

Volltextzugriff (PDF)

Protective Role of Peroxiredoxin I in Heat-Killed Staphylococcus Aureus -infected Mice

In vivo (Athens), 2019-05, Vol.33 (3), p.749-755

2019

Volltextzugriff (PDF)

VDUP1 exacerbates bacteremic shock in mice infected with Pseudomonas aeruginosa

Cellular immunology, 2012-11, Vol.280 (1), p.1-9

2012

Volltextzugriff (PDF)

IL-22 producing NKp46+ innate lymphoid cells can differentiate from hematopoietic precursor cells

Immunology letters, 2011-12, Vol.141 (1), p.61-67

2011

Volltextzugriff (PDF)

Human microRNA-27a targets Prf1 and GzmB expression to regulate NK-cell cytotoxicity

Blood, 2011-11, Vol.118 (20), p.5476-5486

2011

Volltextzugriff (PDF)

16α, 17α-epoxypregnenolone-20-oxime inhibits NO and IL-6 production in LPS-treated RAW264.7 cells

Molecular medicine reports, 2016-06, Vol.13 (6), p.4927-4933

2016

Volltextzugriff (PDF)

Up-regulation of calreticulin in mouse liver tissues after long-term irradiation with low-dose-rate gamma rays

PloS one, 2017-09, Vol.12 (9), p.e0182671-e0182671

2017

Volltextzugriff (PDF)

ROS-Suppression Nanoplatform Combined Activation of STAT3/Bcl‑2 Pathway for Preventing Myocardial Infarction in Mice

ACS applied materials & interfaces, 2024-03, Vol.16 (10), p.12188-12201

2024

Volltextzugriff (PDF)

Mitochondrial aldehyde dehydrogenase 2 accentuates aging-induced cardiac remodeling and contractile dysfunction: role of AMPK, Sirt1, and mitochondrial function

Free radical biology & medicine, 2014-06, Vol.71, p.208-220

2014

Volltextzugriff (PDF)

Discovery of the Clinical Candidate Sonrotoclax (BGB-11417), a Highly Potent and Selective Inhibitor for Both WT and G101V Mutant Bcl‑2

Journal of medicinal chemistry, 2024-05, Vol.67 (10), p.7836-7858

2024

Volltextzugriff (PDF)

Cav1.3 is upregulated in osteoporosis rat model and promotes osteoclast differentiation from preosteoclast cell line RAW264.7

Journal of cellular physiology, 2019-08, Vol.234 (8), p.12821-12827

2019

Volltextzugriff (PDF)

Discovery of orally effective and safe GPR40 agonists by incorporating a chiral, rigid and polar sulfoxide into β-position to the carboxylic acid

European journal of medicinal chemistry, 2023-05, Vol.251, p.115267-115267, Article 115267

2023

Volltextzugriff (PDF)

Sonrotoclax overcomes BCL2 G101V mutation-induced venetoclax resistance in preclinical models of hematologic malignancy

Blood, 2024-05, Vol.143 (18), p.1825

2024

Volltextzugriff (PDF)

Anthelmintic niclosamide attenuates pressure-overload induced heart failure in mice

European journal of pharmacology, 2021-12, Vol.912, p.174614-174614, Article 174614

2021

Volltextzugriff (PDF)

1 – 25 von 30

Suche als RSS-Feed

Aktive Filter

ThemaMice

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(25)
Mit Volltextzugriff
(27)

Publikationsform

Artikel
(30)

Sprache

Erscheinungsjahr

n.n

Thema

Animals
(30)
Science & Technology
(25)
Life Sciences & Biomedicine
(23)
Reactive Oxygen Species - Metabolism
(9)
Humans
(8)
Male
(8)
Reactive Oxygen Species
(8)
Apoptosis
(7)
Cell Line, Tumor
(6)
Mice, Knockout
(6)
Phosphorylation
(6)
Antioxidants
(5)
Cell Line
(5)
Kinases
(5)
Mice, Inbred C57bl
(5)
Microglia
(5)
Peroxiredoxin
(5)
Peroxiredoxins - Genetics
(5)
Peroxiredoxins - Metabolism
(5)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Dominant Role of Peroxiredoxin/JNK Axis in Stemness Regulation During Neurogenesis from Embryonic Stem Cells

Peroxiredoxin I deficiency increases pancreatic β‑cell apoptosis after streptozotocin stimulation via the AKT/GSK3β signaling pathway

BRM270 Suppresses Cervical Cancer Stem Cell Characteristics and Progression by Inhibiting SOX2

Microglial peroxiredoxin V acts as an inducible anti-inflammatory antioxidant through cooperation with redox signaling cascades

Peroxiredoxin II exerts neuroprotective effects by inhibiting endoplasmic reticulum stress and oxidative stress-induced neuronal pyroptosis

Knockdown of peroxiredoxin V increases glutamate‑induced apoptosis in HT22 hippocampal neuron cells

Thioredoxin-Interacting Protein Regulates Hematopoietic Stem Cell Quiescence and Mobilization under Stress Conditions

16α,17α-Epoxypregnenolone-20-oxime Prevent LPS-Induced NO Production and iNOS Expression in BV-2 Microglial Cells by Inhibiting JNK Phosphorylation

Characterization of neural cell types expressing peroxiredoxins in mouse brain

Peroxiredoxin I is a ROS/p38 MAPK-dependent inducible antioxidant that regulates NF-κB-mediated iNOS induction and microglial activation

Peroxiredoxin II with dermal mesenchymal stem cells accelerates wound healing

Peroxiredoxin I Is an Indicator of Microglia Activation and Protects against Hydrogen Peroxide-Mediated Microglial Death

Protective Role of Peroxiredoxin I in Heat-Killed Staphylococcus Aureus -infected Mice

VDUP1 exacerbates bacteremic shock in mice infected with Pseudomonas aeruginosa

IL-22 producing NKp46+ innate lymphoid cells can differentiate from hematopoietic precursor cells

Human microRNA-27a targets Prf1 and GzmB expression to regulate NK-cell cytotoxicity

16α, 17α-epoxypregnenolone-20-oxime inhibits NO and IL-6 production in LPS-treated RAW264.7 cells

Up-regulation of calreticulin in mouse liver tissues after long-term irradiation with low-dose-rate gamma rays

ROS-Suppression Nanoplatform Combined Activation of STAT3/Bcl‑2 Pathway for Preventing Myocardial Infarction in Mice

Mitochondrial aldehyde dehydrogenase 2 accentuates aging-induced cardiac remodeling and contractile dysfunction: role of AMPK, Sirt1, and mitochondrial function

Discovery of the Clinical Candidate Sonrotoclax (BGB-11417), a Highly Potent and Selective Inhibitor for Both WT and G101V Mutant Bcl‑2

Cav1.3 is upregulated in osteoporosis rat model and promotes osteoclast differentiation from preosteoclast cell line RAW264.7

Discovery of orally effective and safe GPR40 agonists by incorporating a chiral, rigid and polar sulfoxide into β-position to the carboxylic acid

Sonrotoclax overcomes BCL2 G101V mutation-induced venetoclax resistance in preclinical models of hematologic malignancy

Anthelmintic niclosamide attenuates pressure-overload induced heart failure in mice

Aktive Filter

Suchergebnisse filtern